The aryl hydrocarbon receptor (AHR) recognizes xenobiotics as well as natural compounds such as tryptophan metabolites, dietary components and microbiota-derived factors1,2,3,4, and it is important for maintenance of homeostasis at mucosal surfaces. AHR activation induces cytochrome P4501 (CYP1) enzymes, which oxygenate AHR ligands, leading to their metabolic clearance and detoxification5. Thus, CYP1 enzymes have an important feedback role that curtails the duration of AHR signalling6, but it remains unclear whether they also regulate AHR ligand availability in vivo. Here we show that dysregulated expression of Cyp1a1 in mice depletes the reservoir of natural AHR ligands, generating a quasi AHR-deficient state. Constitutive expression of Cyp1a1 throughout the body or restricted specifically to intestinal epithelial cells resulted in loss of AHR-dependent type 3 innate lymphoid cells and T helper 17 cells and increased susceptibility to enteric infection. The deleterious effects of excessive AHR ligand degradation on intestinal immune functions could be counter-balanced by increasing the intake of AHR ligands in the diet. Thus, our data indicate that intestinal epithelial cells serve as gatekeepers for the supply of AHR ligands to the host and emphasize the importance of feedback control in modulating AHR pathway activation.
Subscribe to Journal
Get full journal access for 1 year
only $3.90 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Denison, M. S. & Nagy, S. R. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu. Rev. Pharmacol. Toxicol. 43, 309–334 (2003)
Zelante, T. et al. Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. Immunity 39, 372–385 (2013)
McMillan, B. J. & Bradfield, C. A. The aryl hydrocarbon receptor sans xenobiotics: endogenous function in genetic model systems. Mol. Pharmacol. 72, 487–498 (2007)
Moura-Alves, P. et al. AhR sensing of bacterial pigments regulates antibacterial defence. Nature 512, 387–392 (2014)
Schmidt, J. V. & Bradfield, C. A. Ah receptor signaling pathways. Annu. Rev. Cell Dev. Biol. 12, 55–89 (1996)
Chiaro, C. R., Patel, R. D., Marcus, C. B. & Perdew, G. H. Evidence for an aryl hydrocarbon receptor-mediated cytochrome p450 autoregulatory pathway. Mol. Pharmacol. 72, 1369–1379 (2007)
Bock, K. W. & Köhle, C. Ah receptor: dioxin-mediated toxic responses as hints to deregulated physiologic functions. Biochem. Pharmacol. 72, 393–404 (2006)
Kerkvliet, N. I. Recent advances in understanding the mechanisms of TCDD immunotoxicity. Int. Immunopharmacol. 2, 277–291 (2002)
Mitchell, K. A. & Elferink, C. J. Timing is everything: consequences of transient and sustained AhR activity. Biochem. Pharmacol. 77, 947–956 (2009)
Andersson, P. et al. A constitutively active dioxin/aryl hydrocarbon receptor induces stomach tumors. Proc. Natl Acad. Sci. USA 99, 9990–9995 (2002)
Veldhoen, M. et al. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 453, 106–109 (2008)
Veldhoen, M., Hirota, K., Christensen, J., O’Garra, A. & Stockinger, B. Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of TH17 T cells. J. Exp. Med. 206, 43–49 (2009)
Li, Y. et al. Exogenous stimuli maintain intraepithelial lymphocytes via aryl hydrocarbon receptor activation. Cell 147, 629–640 (2011)
Kiss, E. A. et al. Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles. Science 334, 1561–1565 (2011)
Lee, J. S. et al. AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch. Nat. Immunol. 13, 144–151 (2011)
Qiu, J. et al. The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells. Immunity 36, 92–104 (2012)
Lahvis, G. P. et al. The aryl hydrocarbon receptor is required for developmental closure of the ductus venosus in the neonatal mouse. Mol. Pharmacol. 67, 714–720 (2005)
Zheng, Y. et al. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat. Med. 14, 282–289 (2008)
Dragin, N. et al. Phenotype of the Cyp1a1/1a2/1b1−/− triple-knockout mouse. Mol. Pharmacol. 73, 1844–1856 (2008)
Henderson, C. J. et al. Application of a novel regulatable Cre recombinase system to define the role of liver and gut metabolism in drug oral bioavailability. Biochem. J. 465, 479–488 (2015)
Bjeldanes, L. F., Kim, J. Y., Grose, K. R., Bartholomew, J. C. & Bradfield, C. A. Aromatic hydrocarbon responsiveness-receptor agonists generated from indole-3-carbinol in vitro and in vivo: comparisons with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Proc. Natl Acad. Sci. USA 88, 9543–9547 (1991)
Ito, S., Chen, C., Satoh, J., Yim, S. & Gonzalez, F. J. Dietary phytochemicals regulate whole-body CYP1A1 expression through an arylhydrocarbon receptor nuclear translocator-dependent system in gut. J. Clin. Invest. 117, 1940–1950 (2007)
Nguyen, L. P. & Bradfield, C. A. The search for endogenous activators of the aryl hydrocarbon receptor. Chem. Res. Toxicol. 21, 102–116 (2008)
Liu, J. Z. et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat. Genet. 47, 979–986 (2015)
Soshilov, A. A. & Denison, M. S. Ligand promiscuity of aryl hydrocarbon receptor agonists and antagonists revealed by site-directed mutagenesis. Mol. Cell. Biol. 34, 1707–1719 (2014)
Wincent, E. et al. Inhibition of cytochrome P4501-dependent clearance of the endogenous agonist FICZ as a mechanism for activation of the aryl hydrocarbon receptor. Proc. Natl Acad. Sci. USA 109, 4479–4484 (2012)
Srinivas, S. et al. Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus. BMC Dev. Biol. 1, 4 (2001)
Song-Zhao, G. X. et al. Nlrp3 activation in the intestinal epithelium protects against a mucosal pathogen. Mucosal Immunol. 7, 763–774 (2014)
This work was supported by the Francis Crick Institute which receives its core funding from Cancer Research UK, The UK Medical Research Council and the Wellcome Trust. We would like to acknowledge the Biological Research Facility at the Francis Crick Institute for expert breeding and maintenance of our mouse strains, the Histopathology Facility for help with sections and staining and the Flow Cytometry Facility. We thank G. Frankel (Imperial College) for the gift of antiserum to C. rodentium and Genentech, South San Francisco, California, for providing anti-IL-22 and IL-22–Fc. The study was supported by a Wellcome Advanced Investigator Grant (B.S.) and a Sir Henry Wellcome Fellowship and the Fondation Acteria (C.S.). C.H. and C.R.W. are funded by Cancer Research UK Programme Grant C4639/A10822. E.W. is funded by the Swedish Research Council FORMAS and D.N. by National Institute of Environmental Health Sciences, NIH grant R01 ES014403.
The authors declare no competing financial interests.
Reviewer Information Nature thanks H. Sokol and the other anonymous reviewer(s) for their contribution to the peer review of this work.
Extended data figures and tables
a, The endogenous Rosa26 locus, the gene-targeting vector, the targeted Rosa26 allele including the Neo resistance gene cassette (R26Cyp1a1-neoR), the targeted allele (R26LSL-Cyp1a1) after FLPe-mediated recombination and the ubiquitously expressed R26Cyp1a1 are schematically depicted to scale. A minigene composed of the coding sequences of mouse Cyp1a1 and rat Thy1 connected by a 2A sequence followed by the Woodchuck hepatitis virus derived regulatory element (WPRE) and a bovine growth hormone polyadenylation site (bGH pA). b, Expression of rat THY1 in indicated cell types in the colon of R26Cyp1a1, IECCyp1a1 (Vil1-cre-R26LSL-Cyp1a1), Rag1Cyp1a1 (Rag1-cre-R26LSL-Cyp1a1) strains.
Flow cytometry analysis of IL-17A and IL-22 expression in in vitro differentiated TH17 cells from indicated genotypes (day 4) exposed to DMSO, 0.01 nM FICZ or 1 nM FICZ from the start of culture.
Extended Data Figure 3 Altered AHR ligand availability affects intestinal AHR-dependent ILC populations.
a, CYP1A1 enzyme activity, measured by EROD assay, in intestinal tissue homogenates of steady-state mice. b, Flow cytometry analysis of NKp46 and RORγt expression in CD45+ lineage negative (TCRβ–CD3–TCRγδ–CD19–CD11b–Gr1–) Thy1+ live cells in the small intestine (upper panel) and phenotypic analysis of RORγt+NKp46– innate lymphoid cells (lower panel). Results are representative of three independent experiments (n = 3). Error bars, mean + s.e.m. ***P < 0.001, as calculated by one-way ANOVA with Tukey post-test. Source data
a, Liver weight represented as percentage of body weight. b, Liver (left lobe) weight represented as percentage of body weight. Results are representative of two independent experiments. Bars are the mean, each symbol represents an individual mouse. *P < 0.05, **P < 0.01, ***P < 0.001, as calculated by one-way ANOVA with Tukey post-test. Source data
Mice of indicated genotypes were infected orally with ~2 × 109 C. rodentium CFU and killed 7 days after infection or monitored for survival. a, C. rodentium burdens in the colon and caecum. Bars are the median, each symbol represents an individual mouse. b, Colon sections stained for E-cadherin (green), C. rodentium (red) and DAPI (blue). Scale bars, 100 μm. c, Survival plot (WT, n = 4; R26Cyp1a1 + control Ig, n = 6; R26Cyp1a1 + IL-22–Fc, n = 5). Results are representative of three independent experiments. NS, not significant, **P < 0.01, ***P < 0.001, as calculated by one-way ANOVA with Tukey post-test. Source data
a, CD4+ T cells from indicated genotypes were cultured under TH17-cell-inducing conditions and exposed to FICZ from the start of culture. Intracellular levels of FICZ were determined by HPLC and normalized to total protein content at the indicated time points (n = 3 per time point). b, Frequencies of IL-22-producing cells after 4 days of culture under TH17-cell-inducing conditions in presence of indicated concentrations of FICZ. Results are representative of three independent experiments. Error bars, mean + s.e.m. **P < 0.01, ***P < 0.001, as calculated by two-way ANOVA with Dunnett’s post-test (a) or one-way ANOVA with Tukey post-test (b). c, Flow cytometry analysis of Cyp1a1 (eYFP) expression by TH17 cells differentiated from indicated genotypes. Plots are gated on IL-17A+ cells and numbers indicate frequencies. d, Representative flow cytometry plots of IL-17A and IL-22 expression in in vitro differentiated TH17 cells from indicated genotypes (day 4) exposed to DMSO, 0.01 nM FICZ or 1 nM FICZ from the start of culture. e, Mice of indicated genotypes were infected orally with ~2 × 109 C. rodentium CFU and bacterial burdens measured in the faeces at various time points. f, Pathology scores of distal colon. Bars are the mean, symbol represents an individual mouse. Results are representative of at least two independent experiments. NS, not significant. **P < 0.01, ***P < 0.001, as calculated by Student’s t-test. Source data
Mice of indicated genotypes were infected orally with ~2 × 109 C. rodentium CFU and killed 14 days after infection or monitored for survival. a, Survival plot. b, C. rodentium burdens in the colon, caecum, liver and spleen. c, Pathology scores of distal colon and caecum. Bars are the mean, each symbol represents an individual mouse (b, c). d, Absolute numbers of cytokine-producing TCRβ+CD4+ T cells in the colon of mice infected with C. rodentium. Error bars, mean + s.e.m. Results are representative of two independent experiments (n = 5 per group). NS, not significant. **P < 0.01, as calculated by Student’s t-test. Source data
a–c, CYP1A1-mediated metabolism of DIM (a), ICZ (b) and FICZ (c) was studied over time in the presence of human recombinant CYP1A1 (3.5 nM) and the co-factor NADPH (1.0 mM). At indicated time points, samples from respective incubations were extracted and analysed by means of HPLC. All chemicals were quantified according to separate standard curves. Left panels show relative amount of compound remaining at each given time point compared to parallel incubations without co-factor present. Right panels show HPLC chromatograms at 40 min enzyme-incubation, with and without co-factor present. All three compounds were detected on the basis of their fluorescence properties (fluorescence units, FLU). Results are representative of two independent experiments with two biological replicates at each experiment. Error bars, mean + s.d. Source data
About this article
Cite this article
Schiering, C., Wincent, E., Metidji, A. et al. Feedback control of AHR signalling regulates intestinal immunity. Nature 542, 242–245 (2017). https://doi.org/10.1038/nature21080
Targeting Aryl hydrocarbon receptor for next-generation immunotherapies: Selective modulators (SAhRMs) versus rapidly metabolized ligands (RMAhRLs)
European Journal of Medicinal Chemistry (2020)
The AHR pathway represses TGFβ-SMAD3 signalling and has a potent tumour suppressive role in SHH medulloblastoma
Scientific Reports (2020)
Exposure to the AhR agonist cyprodinil impacts the cardiac development and function of zebrafish larvae
Ecotoxicology and Environmental Safety (2020)
Annual Review of Immunology (2020)